Cartesian Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of RNAC for the last quarter is 5.84 M USD, and it's 29.35% lower compared to the previous quarter. The net income of Q1 24 is -56.82 M USD.